PTC Therapeutics (PTCT) PT Lowered to $46 at RBC Capital
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $70.09 -2.4%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on PTC Therapeutics (NASDAQ: PTCT) to $46.00 (from $60.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- PTC Therapeutics to Participate in Upcoming Investor Conferences
- Minimax Group Inc (100:HK) PT Raised to HK$804 at Macquarie
- Macquarie Downgrades Foshan Haitian Flavouring (603288:CH) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
